Fetal Bovine Serum Market share will Increase US$ 872 Million by - Erie News Now | WICU & WSEE in Erie, PA

Fetal Bovine Serum Market share will Increase US$ 872 Million by 2022

Posted:

New York, August 31, 2017 /Financeswire/: Market Research Engine has published a new report titled as “Fetal Bovine Serum Market By Product Type Analysis (Charcoal stripped FBS, Chromatographic purified for low antibody FBS, Dialyzed FBS, Stem cell qualified FBS, Exosome depleted FBS); By Application Analysis (Antibody production, Veterinary applications, Cell culture maintenance, Exosome studies, Immunoassays) By End User Analysis (Research/academic institutes, Diagnostic labs, Cell banks) and by regional analysis – global forecast by 2016 – 2022”.

The global fetal bovine serum market has been segmented based on region of origin, specialty product type, application and end-user. In terms of specialty product type, the global fetal bovine serum market has been segmented into charcoal stripped FBS, chromatographic purified for low antibody FBS, dialyzed FBS, stem cell qualified FBS, exosome depleted FBS, and others. Stem cell qualified FBS is further divided into embryonic stem cells qualified FBS, mesenchymal stem cell-qualified FBS, and others. Based on application, the global fetal bovine serum market has been segmented into antibody production, veterinary applications, cell culture maintenance, exosome studies, immunoassays, and others. The immunoassays segment has been sub-segmented into radiolabeling assays, insulin assay methods, and others. In terms of end-user, the global fetal bovine serum market has been categorized into research/academic institutes, diagnostic labs, cell banks (stem cell banks, tumor cell banks, blood bank, etc.), biopharmaceutical companies, and others.

The Global Fetal bovine serum Market is expected to exceed more than US$ 872 million by 2022 in the given forecast period.

You can browse full report here: https://www.marketresearchengine.com/fetal-bovine-serum-market

The major driving factors of Global Fetal Bovine Serum Market are as follows:

  • Easy for regulatory approvals
  • Cost effective

The restraining factors of Global Fetal bovine Serum Market are as follows:

  • No replacement of FBS
  • Dependent on environmental conditions
  • Ethical problems relating to blood collection method

This report provides:

1) An overview of the global market for Fetal Bovine Serum and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Fetal Serum Bovine Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Report scope:

The scope of the report includes a detailed study of global and regional markets on Fetal Bovine Serum Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sigma-Aldrich Co. LLC., GE Healthcare, Thermo Fisher Scientific Inc., TCS Biosciences Ltd., HiMedia Laboratories, Atlanta Biologicals, Inc., PAN-Biotech, Rocky Mountain Biologicals, BovogenBiologicals Pty Ltd., and Tissue Culture Biologicals, among others. Company profile includes such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

 

Table of Contents

1 INTRODUCTION

2 Research Methodology

3 MARKET OVERVIEW

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 Fetal Bovine Serum by Key Players 2012-2017

7 Fetal Bovine Serum Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

8 COMPANY PROFILES

8.1 Life Technologies

8.2 Thermo Fisher

8.3 GE Healthcare

8.4 Sigma-Aldrich

8.5 Merck

8.7 Gemini

8.8 Atlanta Biologicals

8.9 Tissue Culture Biologicals

 

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

 

Source: http://www.financeswire.com/fetal-bovine-serum-market-share-will-increase-us-872-million-by-2022

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com